AIRSCULPT TECHNOLOGIES INC (AIRS) Fundamental Analysis & Valuation

NASDAQ:AIRS • US0094961002

Current stock price

3.035 USD
+0.31 (+11.17%)
Last:

This AIRS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. AIRS Profitability Analysis

1.1 Basic Checks

  • AIRS had negative earnings in the past year.
  • In the past year AIRS had a positive cash flow from operations.
  • In multiple years AIRS reported negative net income over the last 5 years.
  • AIRS had a positive operating cash flow in each of the past 5 years.
AIRS Yearly Net Income VS EBIT VS OCF VS FCFAIRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

  • AIRS has a worse Return On Assets (-9.67%) than 73.00% of its industry peers.
  • AIRS has a Return On Equity of -21.90%. This is in the lower half of the industry: AIRS underperforms 66.00% of its industry peers.
Industry RankSector Rank
ROA -9.67%
ROE -21.9%
ROIC N/A
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
AIRS Yearly ROA, ROE, ROICAIRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • With an excellent Gross Margin value of 63.97%, AIRS belongs to the best of the industry, outperforming 83.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AIRS has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for AIRS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
AIRS Yearly Profit, Operating, Gross MarginsAIRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. AIRS Health Analysis

2.1 Basic Checks

  • AIRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AIRS has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for AIRS has been increased compared to 5 years ago.
  • The debt/assets ratio for AIRS is higher compared to a year ago.
AIRS Yearly Shares OutstandingAIRS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AIRS Yearly Total Debt VS Total AssetsAIRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • AIRS has an Altman-Z score of 1.32. This is a bad value and indicates that AIRS is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of AIRS (1.32) is worse than 64.00% of its industry peers.
  • The Debt to FCF ratio of AIRS is 23.08, which is on the high side as it means it would take AIRS, 23.08 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 23.08, AIRS is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.63 indicates that AIRS is somewhat dependend on debt financing.
  • The Debt to Equity ratio of AIRS (0.63) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 23.08
Altman-Z 1.32
ROIC/WACCN/A
WACC8.91%
AIRS Yearly LT Debt VS Equity VS FCFAIRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • AIRS has a Current Ratio of 0.51. This is a bad value and indicates that AIRS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.51, AIRS is not doing good in the industry: 88.00% of the companies in the same industry are doing better.
  • AIRS has a Quick Ratio of 0.51. This is a bad value and indicates that AIRS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.51, AIRS is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
AIRS Yearly Current Assets VS Current LiabilitesAIRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AIRS Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 7.14% over the past year.
  • The Revenue for AIRS has decreased by -16.54% in the past year. This is quite bad
  • Measured over the past years, AIRS shows a very strong growth in Revenue. The Revenue has been growing by 34.35% on average per year.
EPS 1Y (TTM)7.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)-16.54%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-17.76%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.55% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, AIRS will show a small growth in Revenue. The Revenue will grow by 2.37% on average per year.
EPS Next Y59.2%
EPS Next 2Y26.17%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue Next Year-17.19%
Revenue Next 2Y-7.85%
Revenue Next 3Y-3.3%
Revenue Next 5Y2.37%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AIRS Yearly Revenue VS EstimatesAIRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
AIRS Yearly EPS VS EstimatesAIRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 -0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

1

4. AIRS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AIRS. In the last year negative earnings were reported.
  • Also next year AIRS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIRS Price Earnings VS Forward Price EarningsAIRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

  • 61.00% of the companies in the same industry are cheaper than AIRS, based on the Enterprise Value to EBITDA ratio.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as AIRS.
Industry RankSector Rank
P/FCF 76.85
EV/EBITDA 40.56
AIRS Per share dataAIRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as AIRS's earnings are expected to grow with 21.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.17%
EPS Next 3Y21.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AIRS Dividend Analysis

5.1 Amount

  • AIRS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AIRS Fundamentals: All Metrics, Ratios and Statistics

AIRSCULPT TECHNOLOGIES INC

NASDAQ:AIRS (4/2/2026, 1:03:57 PM)

3.035

+0.31 (+11.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-02
Earnings (Next)N/A
Inst Owners27.67%
Inst Owner Change-3.4%
Ins Owners36.91%
Ins Owner Change2.71%
Market Cap189.51M
Revenue(TTM)157.55M
Net Income(TTM)-17.98M
Analysts77.78
Price Target6.63 (118.45%)
Short Float %26.08%
Short Ratio1.27
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-1.32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)75.51%
Min EPS beat(2)-96.08%
Max EPS beat(2)247.1%
EPS beat(4)2
Avg EPS beat(4)28.68%
Min EPS beat(4)-103.64%
Max EPS beat(4)247.1%
EPS beat(8)3
Avg EPS beat(8)-16.15%
EPS beat(12)4
Avg EPS beat(12)-36.58%
EPS beat(16)5
Avg EPS beat(16)-86.46%
Revenue beat(2)0
Avg Revenue beat(2)-9.13%
Min Revenue beat(2)-13.2%
Max Revenue beat(2)-5.06%
Revenue beat(4)0
Avg Revenue beat(4)-7.84%
Min Revenue beat(4)-13.2%
Max Revenue beat(4)-1.64%
Revenue beat(8)0
Avg Revenue beat(8)-6.26%
Revenue beat(12)2
Avg Revenue beat(12)-3.89%
Revenue beat(16)5
Avg Revenue beat(16)-2.51%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)16.67%
EPS NQ rev (3m)16.67%
EPS NY rev (1m)0%
EPS NY rev (3m)14.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.2
P/FCF 76.85
P/OCF 22.72
P/B 2.31
P/tB N/A
EV/EBITDA 40.56
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.04
FCFY1.3%
OCF(TTM)0.13
OCFY4.4%
SpS2.52
BVpS1.31
TBVpS-0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.67%
ROE -21.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.97%
FCFM 1.57%
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 23.08
Debt/EBITDA 9.48
Cap/Depr 45.53%
Cap/Sales 3.73%
Interest Coverage N/A
Cash Conversion 152.38%
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z 1.32
F-Score3
WACC8.91%
ROIC/WACCN/A
Cap/Depr(3y)124.96%
Cap/Depr(5y)109.63%
Cap/Sales(3y)6.83%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y59.2%
EPS Next 2Y26.17%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.54%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-17.76%
Revenue Next Year-17.19%
Revenue Next 2Y-7.85%
Revenue Next 3Y-3.3%
Revenue Next 5Y2.37%
EBIT growth 1Y-300.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.41%
EBIT Next 3Y12.29%
EBIT Next 5YN/A
FCF growth 1Y-84.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-67.59%
OCF growth 3Y-24.74%
OCF growth 5Y18.1%

AIRSCULPT TECHNOLOGIES INC / AIRS Fundamental Analysis FAQ

What is the fundamental rating for AIRS stock?

ChartMill assigns a fundamental rating of 2 / 10 to AIRS.


What is the valuation status of AIRSCULPT TECHNOLOGIES INC (AIRS) stock?

ChartMill assigns a valuation rating of 1 / 10 to AIRSCULPT TECHNOLOGIES INC (AIRS). This can be considered as Overvalued.


How profitable is AIRSCULPT TECHNOLOGIES INC (AIRS) stock?

AIRSCULPT TECHNOLOGIES INC (AIRS) has a profitability rating of 2 / 10.


What is the financial health of AIRSCULPT TECHNOLOGIES INC (AIRS) stock?

The financial health rating of AIRSCULPT TECHNOLOGIES INC (AIRS) is 0 / 10.